mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
Irene Olivera(Navarre Institute of Health Research), Ignacio Melero(Navarre Institute of Health Research)
Cited by 44
Related Papers
Cytokines in clinical cancer immunotherapy
|British Journal of Cancer|2018|1.2k
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
|Immunity|2020|749
Immunostimulatory monoclonal antibodies for cancer therapy
|Nature reviews. Cancer|2007|628
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
|Nature Reviews Clinical Oncology|2021|469